TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman January 18, 1991
TCL Archive Only 20 Percent Of At-Risk Patients Are Screened For HBV Before Therapy November 25, 2011
